(Q48712940)

14 February 2018

title

Restless legs syndrome and its treatment by dopamine agonists. (English)

1 reference

14 February 2018

main subject

restless legs syndrome

1 reference

4

Oertel WH

1 reference

14 February 2018

author name string

Stiasny K

series ordinal

1

1 reference

14 February 2018

Wetter TC

series ordinal

2

1 reference

14 February 2018

Trenkwalder C

series ordinal

3

1 reference

14 February 2018

publication date

1 November 2000

1 reference

14 February 2018

number of pages

5

1 reference

Parkinsonism and Related Disorders

inferred from page(s)

published in

1 reference

14 February 2018

volume

7

1 reference

14 February 2018

issue

1

1 reference

14 February 2018

page(s)

21-25

1 reference

14 February 2018

Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900041-9

7 January 2021

Periodic movements in sleep (nocturnal myoclonus): relation to sleep disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900041-9

7 January 2021

Possible relation between restless legs and anaemia in renal dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900041-9

7 January 2021

Clinical and biochemical findings in uremic patients with and without restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900041-9

7 January 2021

Iron status and restless legs syndrome in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900041-9

7 January 2021

Restless leg syndrome in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900041-9

7 January 2021

A clinical, serological and neurophysiological study of restless legs syndrome in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900041-9

7 January 2021

Variable expressivity in familial restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900041-9

7 January 2021

Clinical symptoms and possible anticipation in a large kindred of familial restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900041-9

7 January 2021

L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900041-9

7 January 2021

A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900041-9

7 January 2021

L-dopa in uremic patients with the restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900041-9

7 January 2021

Pergolide in the management of restless legs syndrome: an extended study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900041-9

7 January 2021

Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900041-9

7 January 2021

A randomized controlled study of pergolide in patients with restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900041-9

7 January 2021

Treatment of restless leg syndrome with pergolide--an open clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900041-9

7 January 2021

Restless legs syndrome improved by pramipexole: a double-blind randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900041-9

7 January 2021

Ropinirole for restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900041-9

7 January 2021

10.1016/S1353-8020(00)00041-9

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018